Skip to main content
Home
Zeitschriften
Zeitungen
Podcast
Gesundheitspolitik
Praxis
Allerlei
Jobs
Fachgebiete
Allgemeinmedizin Anästhesiologie & Intensivmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kinder & Jugendheilkunde Neurologie & Psychiatrie Orthopädie & Unfallchirurgie Pflege Urologie Zahnmedizin Apotheke
Subfächer Innere Medizin
Diabetologie Gastroenterologie Infektiologie Kardiologie Onkologie und Hämatologie Pneumologie Rheumatologie
Fortbildungen
Überblick Fortbildungen DFP-Literaturstudium-Artikel DFP-Webcast Fortbildungen DFP-Podcasts
Erweiterte Suche
Anmelden
nach oben
European Surgery
Erschienen in: European Surgery 3/2021

07.05.2021 | perspective

Management of early-stage gallbladder cancer

verfasst von: Doris Wagner, MD, Georg Werkgartner, Klaus Kaczirek

Erschienen in: European Surgery | Ausgabe 3/2021

Einloggen, um Zugang zu erhalten

Excerpt

Gallbladder cancer (GBC) is the fifth most common cancer of the gastrointestinal tract and the most common cancer of the biliary tract [1]. GBC is associated with very poor 5‑year survival rates of only 5–13% [2, 3]. These poor survival rates root in the usually advanced stage of disease at the time of diagnosis and can be attributed to the aggressive nature of GBC as well as the late onset of symptoms like jaundice or pain. Early GBC is usually defined as a tumor confined to the mucosa or the muscularis propria, which corresponds to stages T1a and T1b according to the 8th edition of the American Joint Committee on Cancer (AJCC) guidelines [4]. …
Vorheriger Artikel Management of gallbladder polyps
Literatur
1.
Cherkassky L, D’Angelica M. Gallbladder cancer: managing the incidental diagnosis. Surg Oncol Clin N Am. 2019;28(4):619–30.CrossRef
2.
Soreide K, Guest RV, Harrison EM, Kendall TJ, Garden OJ, Wigmore SJ. Systematic review of management of incidental gallbladder cancer after cholecystectomy. Br J Surg. 2019;106(1):32–45.CrossRef
3.
Erdem S, White RR. Incidental gallbladder cancer: permission to operate. Ann Surg Oncol. 2020;27(4):980–2.CrossRef
4.
Zhu AXPT, Kooby DA, et al. Gallbladder. In: Amin MB, Edge S, Greene F, Byrd DR, Brookland RK, Washington MK, Gershenwald JE, Compton CC, Hess KR, Sullivan DC, Jessup JM, Brierley JD, Gaspar LE, Schilsky RL, Balch CM, Winchester DP, Asare EA, Madera M, Gress DM, Meyer LR, editors. AJCC Cancer Staging Manual. 8th ed. Chicago: Springer; 2017. p. 303.CrossRef
5.
Hickman L, Contreras C. Gallbladder cancer: diagnosis, surgical management, and adjuvant therapies. Surg Clin North Am. 2019;99(2):337–55.CrossRef
6.
Eriksson S, Aronsson B. Medical implications of nosocomial infection with Clostridium difficile. Scand J Infect Dis. 1989;21(6):733–4.CrossRef
7.
Lundgren L, Muszynska C, Ros A, Persson G, Gimm O, Andersson B, et al. Management of incidental gallbladder cancer in a national cohort. Br J Surg. 2019;106(9):1216–27.CrossRef
8.
de Aretxabala X, Oppliger F, Solano N, Rencoret G, Vivanco M, Carvajal D, et al. Laparoscopic management of incidental gallbladder cancer. Surg Endosc. 2018;32(10):4251–5.CrossRef
9.
Vega EA, De Aretxabala X, Qiao W, Newhook TE, Okuno M, Castillo F, et al. Comparison of oncological outcomes after open and laparoscopic re-resection of incidental gallbladder cancer. Br J Surg. 2020;107(3):289–300.CrossRef
10.
Goussous N, Maqsood H, Patel K, Ferdosi H, Muhammad N, Sill AM, et al. Clues to predict incidental gallbladder cancer. Hepatobiliary Pancreat Dis Int. 2018;17(2):149–54.CrossRef
11.
Cherkassky L, Jarnagin W. Selecting treatment sequence for patients with incidental gallbladder cancer: a neoadjuvant approach versus upfront surgery. Updates Surg. 2019;71(2):217–25.CrossRef
12.
Strobel O, Buchler MW. Management and prognosis of incidental gallbladder cancer after cholecystectomy. Chirurg. 2020;91(3):262.CrossRef
13.
Kim JH, Lee JY, Baek JH, Eun HW, Kim YJ, Han JK, et al. High-resolution sonography for distinguishing neoplastic gallbladder polyps and staging gallbladder cancer. AJR Am J Roentgenol. 2015;204(2):W150–W9.CrossRef
14.
DesJardins H, Duy L, Scheirey C, Schnelldorfer T. Porcelain gallbladder: is observation a safe option in select populations? J Am Coll Surg. 2018;226(6):1064–9.CrossRef
15.
Tamandl D, Ba-Ssalamah A, Bohm G, Emmanuel K, Forstner R, Fugger R, et al. Austrian consensus guidelines on imaging requirements prior to hepatic surgery and during follow-up in patients with malignant hepatic lesions. Wien Klin Wochenschr. 2018;130(21–22):665–72.CrossRef
16.
Toren W, Ansari D, Soreide K, Andersson R. Re-resection for incidentally detected gallbladder cancer: weighing in on the options. Eur J Surg Oncol. 2020;46(4 Pt A):495–7.CrossRef
17.
Vega EA, Vinuela E, Okuno M, Joechle K, Sanhueza M, Diaz C, et al. Incidental versus non-incidental gallbladder cancer: index cholecystectomy before oncologic re-resection negatively impacts survival in T2b tumors. HPB. 2019;21(8):1046–56.CrossRef
18.
Wiles R, Thoeni RF, Barbu ST, Vashist YK, Rafaelsen SR, Dewhurst C, et al. Management and follow-up of gallbladder polyps : joint guidelines between the European Society of Gastrointestinal and Abdominal Radiology (ESGAR), European Association for Endoscopic Surgery and other Interventional Techniques (EAES), International Society of Digestive Surgery—European Federation (EFISDS) and European Society of Gastrointestinal Endoscopy (ESGE). Eur Radiol. 2017;27(9):3856–66.CrossRef
19.
Goetze TO, Bechstein WO, Bankstahl US, Keck T, Konigsrainer A, Lang SA, et al. Neoadjuvant chemotherapy with gemcitabine plus cisplatin followed by radical liver resection versus immediate radical liver resection alone with or without adjuvant chemotherapy in incidentally detected gallbladder carcinoma after simple cholecystectomy or in front of radical resection of BTC (ICC/ECC)—a phase III study of the German registry of incidental gallbladder carcinoma platform (GR)—the AIO/ CALGP/ ACO- GAIN-trial. BMC Cancer. 2020;20(1):122.CrossRef
20.
Ustaalioglu OBB, Bilici A, Seker M, Kefeli U, Aydin D, Celik S, et al. Prognostic factors for operated gallbladder cancer. J Gastrointest Cancer. 2019;50(3):451–7.CrossRef
21.
de Savornin Lohman EAJ, van der Geest LG, de Bitter TJJ, Nagtegaal ID, van Laarhoven C, van den Boezem P, et al. Re-resection in incidental gallbladder cancer: survival and the incidence of residual disease. Ann Surg Oncol. 2020;27(4):1132–42.CrossRef
22.
Aloia TA, Jarufe N, Javle M, Maithel SK, Roa JC, Adsay V, et al. Gallbladder cancer: expert consensus statement. HPB. 2015;17(8):681–90.CrossRef
23.
Kim BH, Kim SH, Song IS, Chun GS. The appropriate surgical strategy for T1b gallbladder cancer incidentally diagnosed after a simple cholecystectomy. Ann Hepatobiliary Pancreat Surg. 2019;23(4):327–33.CrossRef
24.
Lee H, Choi DW, Park JY, Youn S, Kwon W, Heo JS, et al. Surgical strategy for T2 gallbladder cancer according to tumor location. Ann Surg Oncol. 2015;22(8):2779–86.CrossRef
Metadaten
Titel
Management of early-stage gallbladder cancer
verfasst von
Doris Wagner, MD
Georg Werkgartner
Klaus Kaczirek
Publikationsdatum
07.05.2021
Verlag
Springer Vienna
Erschienen in
European Surgery / Ausgabe 3/2021
Print ISSN: 1682-8631
Elektronische ISSN: 1682-4016
DOI
https://doi.org/10.1007/s10353-021-00718-8

Weitere Artikel der Ausgabe 3/2021

European Surgery 3/2021 Zur Ausgabe

editorial

Surgery unites the world: beyond R0 resection of greed, envy and hate.

main topic

Challenging situations in cholecystectomy and strategies to overcome them

main topic

Management of gallbladder polyps

editorial

European Surgery—publisher’s report 2020

main topic

The “critical view of safety (CVS)” cannot be applied—What to do? Strategies to avoid bile duct injuries

editorial

Surgery of the gallbladder